150 related articles for article (PubMed ID: 3103712)
1. Mediastinal lymphoma of clear cell type is a tumor corresponding to terminal steps of B cell differentiation.
Möller P; Moldenhauer G; Momburg F; Lämmler B; Eberlein-Gonska M; Kiesel S; Dörken B
Blood; 1987 Apr; 69(4):1087-95. PubMed ID: 3103712
[TBL] [Abstract][Full Text] [Related]
2. The primary mediastinal clear cell lymphoma of B-cell type has variable defects in MHC antigen expression.
Möller P; Lämmler B; Herrmann B; Otto HF; Moldenhauer G; Momburg F
Immunology; 1986 Nov; 59(3):411-7. PubMed ID: 3491784
[TBL] [Abstract][Full Text] [Related]
3. Immunophenotypic similarities of mediastinal clear-cell lymphoma and sinusoidal (monocytoid) B cells.
Möller P; Matthaei-Maurer DU; Hofmann WJ; Dörken B; Moldenhauer G
Int J Cancer; 1989 Jan; 43(1):10-6. PubMed ID: 2783413
[TBL] [Abstract][Full Text] [Related]
4. Mediastinal large-cell lymphoma of B-type, with sclerosis: histopathological and immunohistochemical study of eight cases.
Menestrina F; Chilosi M; Bonetti F; Lestani M; Scarpa A; Novelli P; Doglioni C; Todeschini G; Ambrosetti A; Fiore-Donati L
Histopathology; 1986 Jun; 10(6):589-600. PubMed ID: 3525372
[TBL] [Abstract][Full Text] [Related]
5. Primary mediastinal clear cell lymphoma of B-cell type.
Möller P; Lämmler B; Eberlein-Gonska M; Feichter GE; Hofmann WJ; Schmitteckert H; Otto HF
Virchows Arch A Pathol Anat Histopathol; 1986; 409(1):79-92. PubMed ID: 3085342
[TBL] [Abstract][Full Text] [Related]
6. Lineage differentiation of canine lymphoma/leukemias and aberrant expression of CD molecules.
Wilkerson MJ; Dolce K; Koopman T; Shuman W; Chun R; Garrett L; Barber L; Avery A
Vet Immunol Immunopathol; 2005 Jul; 106(3-4):179-96. PubMed ID: 15963817
[TBL] [Abstract][Full Text] [Related]
7. Cell surface markers in leukemia: biological and clinical correlations.
Thiel E
Crit Rev Oncol Hematol; 1985; 2(3):209-60. PubMed ID: 3013441
[TBL] [Abstract][Full Text] [Related]
8. Immunologic markers in non-Hodgkin's lymphoma.
Freedman AS; Nadler LM
Hematol Oncol Clin North Am; 1991 Oct; 5(5):871-89. PubMed ID: 1938759
[TBL] [Abstract][Full Text] [Related]
9. Monoclonal antibodies of IPO series against B cell differentiation antigens in leukemia and lymphoma immunophenotyping.
Sidorenko SP; Vetrova EP; Yurchenko OV; Berdova AG; Shlapatskaya LN; Gluzman DF
Neoplasma; 1992; 39(1):3-9. PubMed ID: 1528302
[TBL] [Abstract][Full Text] [Related]
10. Non-T, non-B lymphomas are rare in childhood and associated with cutaneous tumor.
Bernard A; Murphy SB; Melvin S; Bowman WP; Caillaud J; Lemerle J; Boumsell L
Blood; 1982 Mar; 59(3):549-54. PubMed ID: 6977384
[TBL] [Abstract][Full Text] [Related]
11. Expression of the T1 (CD5, p67) surface antigen in B-CLL and B-NHL and its correlation with other B-cell differentiation markers.
Delia D; Bonati A; Giardini R; Villa S; De Braud F; Cattoretti G; Rilke F
Hematol Oncol; 1986; 4(3):237-48. PubMed ID: 3095211
[TBL] [Abstract][Full Text] [Related]
12. Biphenotypic leukemic lymphocyte precursors in CD2+CD19+ acute lymphoblastic leukemia and their putative normal counterparts in human fetal hematopoietic tissues.
Uckun FM; Muraguchi A; Ledbetter JA; Kishimoto T; O'Brien RT; Roloff JS; Gajl-Peczalska K; Provisor A; Koller B
Blood; 1989 Mar; 73(4):1000-15. PubMed ID: 2784064
[TBL] [Abstract][Full Text] [Related]
13. B-cell malignancies and differentiation antigens defined with monoclonal antibodies.
Kikuchi K; Koshiba H; Kasai K; Hiratsuka H; Fujimoto N; Uede T
Jpn J Clin Oncol; 1983 Sep; 13(3):517-31. PubMed ID: 6417375
[TBL] [Abstract][Full Text] [Related]
14. Cytologic, immunologic, and clinical diversity in non-Hodgkin's lymphoma: therapeutic implications.
Urba WJ; Longo DL
Semin Oncol; 1985 Sep; 12(3):250-67. PubMed ID: 3931224
[No Abstract] [Full Text] [Related]
15. B-lymphocyte associated differentiation antigen expression by 'non-B, non-T' acute lymphoblastic leukemia.
Flug F; Dodson L; Wolff J; Guarini L; Rausen A; Wang CY; Knowles DM
Leuk Res; 1985; 9(8):1051-8. PubMed ID: 2931557
[TBL] [Abstract][Full Text] [Related]
16. Detailed phenotypic analysis of B-cell lymphoma using a panel of antibodies reactive in routinely fixed wax-embedded tissue.
Norton AJ; Isaacson PG
Am J Pathol; 1987 Aug; 128(2):225-40. PubMed ID: 3113255
[TBL] [Abstract][Full Text] [Related]
17. Differentiation antigens in acute leukaemia.
Reen DJ
Biochem Soc Trans; 1985 Apr; 13(2):420-2. PubMed ID: 3926556
[No Abstract] [Full Text] [Related]
18. Antibodies to CD40 prevent Epstein-Barr virus-mediated human B-cell lymphomagenesis in severe combined immune deficient mice given human peripheral blood lymphocytes.
Murphy WJ; Funakoshi S; Beckwith M; Rushing SE; Conley DK; Armitage RJ; Fanslow WC; Rager HC; Taub DD; Ruscetti FW
Blood; 1995 Sep; 86(5):1946-53. PubMed ID: 7544649
[TBL] [Abstract][Full Text] [Related]
19. Association of colorectal tumor epithelium expressing HLA-D/DR with CD8-positive T-cells and mononuclear phagocytes.
Allen CA; Hogg N
Cancer Res; 1987 Jun; 47(11):2919-23. PubMed ID: 3105871
[TBL] [Abstract][Full Text] [Related]
20. Clonal immunoglobulin gene rearrangements in primary mediastinal clear cell lymphomas.
Brandter LB; Smith CI; Hammarström L; Lindemalm C; Christensson B
Leukemia; 1989 Feb; 3(2):122-9. PubMed ID: 2911206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
